Search

everythinglearnresearchcommunity

for

Search:↓

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Cobalt is important for health but too much or too little can cause health problems, and its environmental buildup is a concern.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

ABO/Rh blood groups are not a risk factor for PCOS.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Skin, hair, and nail changes can help detect eating disorders early.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

Some vitamins, amino acids, and alternative medicines can cause serious side effects, including bone, muscle, and skin issues, and healthcare professionals should be aware of these risks.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Hair loss in lupus patients indicates higher disease activity.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

The supplement helps improve hair growth and reduce hair shedding.

The guideline provides recommendations for managing alopecia areata effectively.